Precipio, Inc. (PRPO) Investor Relations Documents

Precipio, Inc. (PRPO) investor relations documents from the company's IR site: 2 presentations, 24 press releases; latest deck 2025-08-17. Read in-app with summaries. First-party data.

Learn More — Precipio, Inc. (NASDAQ: PRPO) is a New Haven-based diagnostics biotech company founded in 2011, providing general corporate background and forward-looking statements.

Investor relations documents — source: company IR site
PublishedTypeDocument
2026-08-14Press releasePrecipio Announces Q2-2026 Financial Results
2026-07-31Press releasePrecipio Announces Q2-2026 Shareholder Update Call
2026-06-12Press releasePrecipio is requesting Shareholders/Brokers vote today to avoid costly adjournment and rescheduling of Annual Shareholde
2026-06-11Press releasePrecipio to Present at the Planet MicroCap Las Vegas
2026-05-14Press releasePrecipio Announces Q1 2026 Financial Results
2026-05-13Press releaseManagement team’s 2025 market-based Options have vested
2026-05-06Press releasePrecipio Announces Q1-2026 Shareholder Update Call
2026-03-12Press releasePrecipio Announces Q4 and year-end 2025 Shareholder Update Call
2026-03-10Press releasePrecipio Announces Publication of a Joint Study with Memorial Sloan-Kettering Cancer Center Highlighting Its Cutting-Edg
2026-01-15Press releasePrecipio Takes Major Steps Toward a Clean Balance Sheet
2025-12-05Press releasePrecipio to Showcase its BCR::ABL1 panel at 2025 ASH (American Society of Hematology) Meeting
2025-12-04Press releasePrecipio Identifies Unauthorized Access to Isolated Storage; No Operational Impact
2025-11-14Press releasePrecipio Announces its Q3-2025 Financial Results
2025-11-04Press releasePrecipio Announces Q3-2025 Shareholder Update Call
2025-09-02Press releasePrecipio Terminates Its ATM
2025-08-17PresentationLearn More
2025-07-11Press releasePrecipio Enters Into Agreement With Warrant Holder To Exercise Majority Of Warrants As Cashless
2025-05-14Press releasePrecipio Announces its Q1-2025 Financial Results
2025-05-01Press releasePrecipio Announces Q1-2025 Shareholder Update Call
2025-03-17Press releasePrecipio Announces Q4 and year-end 2024 Shareholder Update Call
2025-02-25Press releasePrecipio 2025 (Unaudited) Revenues Grew to $24.0M, a 30% Increase Year-Over-Year
2025-01-16Press releasePrecipio grants senior management performance-based awards instead of traditional time-vested ESOPs
2024-09-06Press releasePrecipio Announces Employee Stock Option Plan Repricing
2024-08-15Press releasePrecipio Announces Q2-2024 Shareholder Update Call
2024-07-25Press releasePrecipio Reports $0.3M cash generated by operations (unaudited) in Q2-2024, as the company advances towards breakeven
2023-05-04PresentationPrecipio’s Omnia™ Methodology Identifies Mixed Phenotype Patient with Aggressive MDS Transformation and MPN on Periphera

PRPO overview · PRPO earnings · PRPO financials · PRPO KPIs · PRPO ownership · PRPO peers · PRPO filings

Documents published by the company on its investor-relations site; summaries are model-written. Not personalized investment advice.